APA (7th ed.) Citation

L, M., M, T., A, F., PK, S., E, P., S, M., . . . F, B. (2026). New therapeutic strategies for Lafora disease: Evaluation of the safety, efficacy, pharmacokinetics and metabolomic profile of intravenous VAL-1221 treatment. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 23(1), e00808. https://doi.org/10.1016/j.neurot.2025.e00808

Chicago Style (17th ed.) Citation

L, Muccioli, et al. "New Therapeutic Strategies for Lafora Disease: Evaluation of the Safety, Efficacy, Pharmacokinetics and Metabolomic Profile of Intravenous VAL-1221 Treatment." Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics 23, no. 1 (2026): e00808. https://doi.org/10.1016/j.neurot.2025.e00808.

MLA (9th ed.) Citation

L, Muccioli, et al. "New Therapeutic Strategies for Lafora Disease: Evaluation of the Safety, Efficacy, Pharmacokinetics and Metabolomic Profile of Intravenous VAL-1221 Treatment." Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics, vol. 23, no. 1, 2026, p. e00808, https://doi.org/10.1016/j.neurot.2025.e00808.